Average Co-Inventor Count = 8.67
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (12 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (6 from 2,405 patents)
3. Pharmacopeia Drug Discovery, Inc. (3 from 52 patents)
4. The United States of America, as Represented by the Secretary, Department of Health and Human Services (2 from 3,540 patents)
5. Other (1 from 832,912 patents)
6. Pharmacopeia Inc. (1 from 101 patents)
7. Schering-Plough Corporation (1 from 28 patents)
22 patents:
1. 8889683 - Substituted quinoxalines as inhibitors of fatty acid binding protein
2. 8815875 - Inhibitors of fatty acid binding protein (FABP)
3. 8778980 - Heterocyclic aspartyl protease inhibitors
4. 8759357 - Inhibitors of fatty acid binding protein (FABP)
5. 8557798 - Macrocyclic heterocyclic aspartyl protease inhibitors
6. 8357682 - Gamma secretase modulators
7. 8278334 - Cyclic amine BACE-1 inhibitors having a benzamide substituent
8. 8242112 - Heterocyclic aspartyl protease inhibitors
9. 8178513 - Heterocyclic aspartyl protease inhibitors
10. 8012953 - Macrocyclic beta-secretase inhibitors
11. 7973067 - Heterocyclic aspartyl protease inhibitors
12. 7910590 - Cyclic amine bace-1 inhibitors having a heterocyclic substituent
13. 7868000 - Aspartyl protease inhibitors
14. 7812013 - Macrocyclic heterocyclic aspartyl protease inhibitors
15. 7763609 - Heterocyclic aspartyl protease inhibitors